BrainsWay Receives ARTG Approval for Marketing its Deep TMS Treatment for Depression in Australia
BrainsWay to Expand its Activities in Australia, Previously Focused on Research JERUSALEM, June 29, 2015. BrainsWay® Ltd. (TASE: BRIN)...
top of page
News & Events
Jun 2, 2015
UCSD psychiatrist David Feifel uses Deep TMS to help Depression patient
Jay Martin, a patient who has struggled with depression for decades, describes BrainsWay® Deep TMS as a Godsend, after being treated at...
Feb 9, 2015
World Psychiatry Journal 02/2015: Multicenter double blinded randomized controlled trial results,
World Psychiatry Journal 02/2015: Multicenter double blinded randomized controlled trial results show BrainsWay Deep TMS to be...
Jan 10, 2013
BrainsWay Receives FDA Clearance
JERUSALEM, Thursday 10, 2013 BrainsWay® Ltd. (TASE: BRIN) is proud to announce that the U.S. Food and Drug Administration (“FDA”) has...
bottom of page